Sly Saint
Senior Member (Voting Rights)
Presentation (PDF Available) · July 2018 with 37 Reads
DOI: 10.13140/RG.2.2.29883.52009
British Association of Behavioural and Cognitive Psychotherapy, DOI:10.13140/RG.2.2.29883.52009
https://www.researchgate.net/public...ealth_anxiety_in_Chronic_Fatigue_Syndrome_CFS
10 patients.
This is the Dr Jo Daniels on the NICE guidelines committee(?)
DOI: 10.13140/RG.2.2.29883.52009
British Association of Behavioural and Cognitive Psychotherapy, DOI:10.13140/RG.2.2.29883.52009
ABSTRACT
Introduction: Chronic Fatigue Syndrome (CFS) is a debilitating condition that affects 0.2–0.4% of the population. First-line treatments are Cognitive Behaviour Therapy or graded exercise therapy; however these evidence based treatments yield only moderate effect sizes.
Emerging research suggests that anxiety about health is common across medical complaints, with small scale studies suggesting it may be common in CFS.
The aim of this study was to identify the prevalence of health anxiety in a CFS sample, and assess whether anxiety, depression and health anxiety account for the in primary outcome variables (physical functioning, fatigue).
A secondary aim was to test the acceptability and effectiveness of an adapted CBT intervention for health anxiety (CBT-HA).
Method:
Firstly, a cross sectional questionnaire study was used to assess prevalence of health anxiety in CFS. Data were taken from the Short Health Anxiety Inventory (SHAI) and the Hospital Anxiety and Depression Scale. Primary outcome variables included physical functioning and fatigue.
Secondly, a consecutive case-series design was used to assess effectiveness and acceptability of the CBT-HA treatment model for CFS and health anxiety. Participants were those who scored in the clinical range on the SHAI (>18) with a positive diagnosis of CFS.
Results: 42% of the CFS sample demonstrated clinically severe health anxiety(HA) (>18). T-tests grouping low and high HA indicated that those with high HA scored significantly poorer across all physical and psychological measures than those with low health anxiety. Significant associations between between anxiety, depression and health anxiety and outcome variables physical functioning, fatigue were in expected directions.
Stepwise regression analyses indicated that in a single factor model, physical functioning accounted for 12% of the variance in fatigue. Health anxiety, anxiety and depression were non-significant predictors.
For physical functioning, a three-factor model including depression (r2=.21) fatigue (.057) and health anxiety (.023), accounting for 28.3% of the variance, indicating a moderating effect of health anxiety, but not anxiety.
All ten patients completed 5 or more sessions of therapy, with two participants (20%) withdrawing at session 6. Of those who completed a full course of therapy, 100% achieved reliable and clinically significant change in both fatigue and health anxiety excepting one who did not achieve significant change in fatigue (Reliable Change Index).
Half of those who completed therapy no longer met criteria for CFS on a Fukuda checklist.
Conclusions:
This is the first study to robustly examine high prevalence of health anxiety in CFS, acting as a larger scale replica of earlier studies by the same research group.
This study supports the use of the SHAI as a useful tool in the CFS population for purposes of identification, and also use of an empirically grounded, evidence based treatment model for co-morbid anxiety. This offers a novel treatment option easily implemented and utilised in other CFS services through use of the protocolised CBT-HA.
https://www.researchgate.net/public...ealth_anxiety_in_Chronic_Fatigue_Syndrome_CFS
10 patients.
This is the Dr Jo Daniels on the NICE guidelines committee(?)